Prague Med. Rep. 2025, 126, 30-35
https://doi.org/10.14712/23362936.2025.5
A Case of Pleuroparenchymal Fibroelastosis
References
1. 1992) Idiopathic pulmonary upper lobe fibrosis (IPUF). Kokyu 11(2), 693–699. (in Japanese)
, R., Niimi, A., Kuse, F. (
2. 2022) Pleuroparenchymal fibroelastosis. Curr. Opin. Pulm. Med. 28(5), 432–440.
< , V., Si-Mohamed, S., Diesler, R., Bonniaud, P., Valenzuela, C. (https://doi.org/10.1097/MCP.0000000000000907>
3. 2017) Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: A retrospective multicenter study. Respir. Med. 133, 1–5.
< , Y., Nakamura, Y., Satake, Y., Sumikawa, H., Johkoh, T., Colby, T. V., Yasui, H., Hozumi, H., Karayama, M., Suzuki, Y., Furuhashi, K., Fujisawa, T., Enomoto, N., Inui, N., Iwashita, T., Kuroishi, S., Yokomura, K., Koshimizu, N., Toyoshima, M., Imokawa, S., Yamada, T., Shirai, T., Hayakawa, H., Suda, T. (https://doi.org/10.1016/j.rmed.2017.11.003>
4. 2019) Cause of pleuroparenchymal fibroelastosis following allogeneic hematopoietic stem cell transplantation. Respir. Investig. 57(4), 321–324.
< , H., Miyahara, N., Taniguchi, A., Maeda, Y., Kiura, K. (https://doi.org/10.1016/j.resinv.2019.04.003>
5. 2022) Radiological unilateral pleuroparenchymal fibroelastosis as a notable late complication after lung cancer surgery: Incidence and perioperative associated factors. Interact. Cardiovasc. Thorac. Surg. 35(4), ivac223.
< , K., Sekine, A., Arai, H., Hagiwara, E., Komatsu, S., Iwasawa, T., Misumi, T., Kikunishi, N., Tajiri, M., Okudela, K., Rino, Y., Ogura, T. (https://doi.org/10.1093/icvts/ivac223>
6. 2018) Pleuroparenchymal fibroelastosis diagnosed by multidisciplinary discussions in Japan. Respir. Med. 141, 190–197.
< , H., Watanabe, K., Kushima, H., Baba, T., Watanabe, S., Yamada, Y., Arai, T., Tsushima, K., Kondoh, Y., Nakamura, Y., Terasaki, Y., Hebisawa, A., Johkoh, T., Sakai, F., Takemura, T., Kawabata, Y., Ogura, T.; Tokyo Diffuse Lung Disease Study Group (https://doi.org/10.1016/j.rmed.2018.06.022>
7. 2017) Proliferation of elastic fibres in idiopathic pulmonary fibrosis: A whole-slide image analysis and comparison with pleuroparenchymal fibroelastosis. Histopathology 71(6), 934–942.
< , Y., Watanabe, K., Ishii, H., Kushima, H., Fujita, M., Nabeshima, K. (https://doi.org/10.1111/his.13312>
8. 2022) Limited efficacy of nintedanib for idiopathic pleuroparenchymal fibroelastosis. Respir. Investig. 60(4), 562–569.
< , Y., Miyamura, T., Ikeda, T., Ueda, Y., Yoshida, Y., Kushima, H., Ishii, H. (https://doi.org/10.1016/j.resinv.2022.03.001>
9. Kinoshita, Y., Utsunomiya, T., Koide, Y., Wada, K., Ueda, Y., Yoshida, Y., Kushima, H., Ishii, H. (2023) Changes in body weight reflect disease progression in pleuroparenchymal fibroelastosis. Respir. Med. Res. 83, 100980.
<https://doi.org/10.1016/j.resmer.2022.100980>
10. 2021) Prognostic and clinical value of cluster analysis in idiopathic pleuroparenchymal fibroelastosis phenotypes. J. Clin. Med. 10(7), 1498.
< , Y., Mori, K., Enomoto, Y., Kono, M., Sumikawa, H., Johkoh, T., Colby, T. V., Yasui, H., Hozumi, H., Karayama, M., Suzuki, Y., Furuhashi, K., Fujisawa, T., Enomoto, N., Inui, N., Kaida, Y., Yokomura, K., Koshimizu, N., Toyoshima, M., Imokawa, S., Yamada, T., Shirai, T., Nakamura, H., Hayakawa, H., Suda, T. (https://doi.org/10.3390/jcm10071498>
11. 2021) Nintedanib in idiopathic and secondary pleuroparenchymal fibroelastosis. Orphanet J. Rare Dis. 16(1), 419.
< , M., Si-Mohamed, S., Turquier, S., Traclet, J., Ahmad, K., Philit, F., Bonniaud, P., Chalabreysse, L., Thivolet-Béjui, F., Cottin, V. (https://doi.org/10.1186/s13023-021-02043-5>
12. 2021) Comparison of clinical characteristics and outcomes between idiopathic and secondary pleuroparenchymal fibroelastosis. J. Clin. Med. 10(4), 846.
< , T., Sekine, A., Tabata, E., Iwasawa, T., Takemura, T., Ogura, T. (https://doi.org/10.3390/jcm10040846>
13. Rasciti, E., Cancellieri, A., Romagnoli, M., Dell’Amore, A., Zompatori, M. (2019) Suspected pleuroparenchymal fibroelastosis relapse after lung transplantation: A case report and literature review. BJR Case Rep. 5(4), 20190040.
<https://doi.org/10.1259/bjrcr.20190040>
14. 2017) Unilateral upper lung field pulmonary fibrosis radiologically consistent with pleuroparenchymal fibroelastosis after thoracotomy: A new disease entity related to thoracotomy. Respiration 94(5), 431–441.
< , A., Satoh, H., Iwasawa, T., Matsui, K., Ikeya, E., Ikeda, S., Yamakawa, H., Okuda, R., Kitamura, H., Shinohara, T., Baba, T., Komatsu, S., Kato, T., Hagiwara, E., Ogura, T. (https://doi.org/10.1159/000479331>
15. 2021) Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia. ERJ Open Res. 7(1), 00196-2020.
< , K., Ono, H., Shimizu, H., Kurosawa, T., Matsumoto, K., Ando, M., Mori, K., Tsuboi, E., Homma, S., Kishi, K. (https://doi.org/10.1183/23120541.00196-2020>
16. 2023) Assessment of malnutrition-related risk in patients with idiopathic pleuroparenchymal fibroelastosis. ERJ Open Res. 9(3), 00749-2022.
< , Y., Fukada, A., Mori, K., Kono, M., Hasegawa, H., Hashimoto, D., Yokomura, K., Imokawa, S., Inoue, Y., Yasui, H., Hozumi, H., Karayama, M., Furuhashi, K., Enomoto, N., Fujisawa, T., Inui, N., Nakamura, H., Suda, T. (https://doi.org/10.1183/23120541.00749-2022>
17. 2013) An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 188(6), 733–748.
< , W. D., Costabel, U., Hansell, D. M., King, T. E. Jr., Lynch, D. A., Nicholson, A. G., Ryerson, C. J., Ryu, J. H., Selman, M., Wells, A. U., Behr, J., Bouros, D., Brown, K. K., Colby, T. V., Collard, H. R., Cordeiro, C. R., Cottin, V., Crestani, B., Drent, M., Dudden, R. F., Egan, J., Flaherty, K., Hogaboam, C., Inoue, Y., Johkoh, T., Kim, D. S., Kitaichi, M., Loyd, J., Martinez, F. J., Myers, J., Protzko, S., Raghu, G. Richeldi, L., Sverzellati, N., Swigris, J., Valeyre, D.; ATS/ERS Committee on Idiopathic Interstitial Pneumonias (https://doi.org/10.1164/rccm.201308-1483ST>